SLC7A11 and non-small cell lung carcinoma: Moreover, Ji et al. showed that highly expressed cystine-glutamate transporter (SLC7A11) mediated metabolic requirements during NSCLC progression and predicted a worse 5-year survival (Ji et al., 2018).